Novel therapeutic approaches and drug-delivery technologies are improving control of pain and inflammation after cataract and other ocular surgeries.
Physicians hear from well-intentioned patients all the time about their efforts to instill medications into their eyes perioperatively.
The scenarios can vary from instilling too many or too few drops of the correct medications into the eye, forgetting to administer their drops at all, instilling the wrong drugs into the right place, or missing the mark altogether.
In any case, the end result is the same: the prescribed drugs are not going where they are intended to go and the desired therapeutic effect—that is, alleviation of pain and inflammation—does not happen.
A number of new advances in drug delivery have been introduced over the past 1 to 2 years that are helping patients who have undergone cataract surgery and who are having trouble instilling drugs more easily reap the benefits of their prescribed medications, according to Alice Epitropoulos, MD.
The real advantage is that the novel technologies facilitate compliance and overall patient care, said Dr. Epitropoulos, clinical assistant professor, The Ohio State University Wexner Medical Center and private practice, Columbus, OH.
Dr. Epitropoulos expressed her appreciation of the availability of these formulations in her drug armamentarium “because they will elevate the level of patient care by alleviating the age-old problems associated with compliance,” she said.
Alice Epitropoulos, MD
E: [email protected]
Dr. Epitropoulos is a speaker and/or consultant for Bausch + Lomb, EyePoint Pharmaceuticals, Kala Pharmaceuticals, Ocular Therapeutix, and Omeros.